- Home
- CLRO vs TRIB Comparison
CLRO vs TRIB Comparison
Compare CLRO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRO | TRIB |
|---|---|---|
| Founded | 1983 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 8.4M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLRO | TRIB |
|---|---|---|
| Price | $3.45 | $7.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 720.9K | 12.4K |
| Earning Date | 11-13-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,067,000.00 | N/A |
| Revenue This Year | N/A | $35.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.59 | N/A |
| 52 Week Low | $1.62 | $0.28 |
| 52 Week High | $16.50 | $14.17 |
Technical Indicators
Market Signals| Indicator | CLRO | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 51.16 |
| Support Level | $2.95 | $6.85 |
| Resistance Level | $3.88 | $8.77 |
| Average True Range (ATR) | 0.58 | 1.00 |
| MACD | -0.09 | 0.17 |
| Stochastic Oscillator | 50.90 | 55.69 |
Price Performance
Historical ComparisonAbout CLRO ClearOne Inc. (DE)
ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.